2 results
Approved WMOCompleted
The study will be conducted in two parts, Part A and Part B. The main purpose of Part A of the study is to evaluate the safety and tolerability, the blood levels and the extent of receptor blockade of CCX872-B in patients with pancreatic cancer. In…
Approved WMOCompleted
Part 1: To evaluate the effects of BIIB033 versus placebo on disability improvement over 72 weeks.Part 2: evaluate long-term safety profile of BIIB033 as an add-on therapy in subjects with MS.